arrow
B

Blachy J. Dávila Saldaña

Childrens National Hospital
H指数:23
被引数:2,012

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report

造血细胞移植治疗Wiskott-Aldrich综合征:一份PIDTC报告

2025-12-080
OAAI
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH study

emapalumab 在美国恶性肿瘤相关性噬血细胞性淋巴组织细胞增多症中的应用:REAL-HLH 研究

2025-12-050
OAAI
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature

多组学分析揭示人类RAG缺陷症表现出独特的免疫失调模式,但具有共同的炎症特征

2025-01-010
OA
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation

儿科移植与细胞治疗联盟RESILIENT会议:造血细胞移植后儿科慢性移植物抗宿主病生存状况——第二部分。造血细胞移植后儿童慢性移植物抗宿主病的器官功能障碍与免疫重建考量。

2025-01-010
PRE
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy

异基因造血干细胞移植治疗重型再生障碍性贫血: 美国移植与细胞治疗学会循证指南

2024-12-011
OAAI
Reconstitution of Norovirus-Specific T-Cell Responses Following Hematopoietic Stem Cell Transplantation in Patients With Inborn Errors of Immunity and Chronic Norovirus Infection
2024-08-140
PRE
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab
2024-05-143
OAAI
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study
2024-05-013
PRE
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
2024-04-183
OAAI
Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study
2024-01-014
OAAI
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune DeficiencyTreatment Consortium
LANCET
IF88.5
2023-07-0130
OAAI
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions
2023-02-0119
OAAI
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation
2023-01-012
OAAI
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial
2022-09-0138
OAAI
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders
2022-03-0120
OAAI